Yibai Pharmaceutical: Abnormal fluctuations in stock trading do not exist undisclosed significant information that should be disclosed.

Yibai Pharmaceutical announced that the closing prices of the company's stock on March 31, April 1, and April 2 in 2026 have deviated by more than 20% for three consecutive trading days, indicating abnormal fluctuations. After self-examination and verification with the controlling shareholders and actual controllers, as of the date of the announcement, the company's production and operations are normal, and there have been no significant adjustments in the market environment or industry policies. There is no significant information that should be disclosed but has not been disclosed. The company reminds investors to pay attention to trading risks.